TapewireFind a company

person · Reporting owner

Okupe Oluyemi

Disclosed activity across 1 company

Tapewire entity
21133
SEC CIK
0001907056

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Chief Financial OfficerOctober 01, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date October 01, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect234,527 Reported balance After 2026-10-01 transaction · row 1
1 source row

Row 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 3, 2026 00:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 2,000 $29.70 $59,400.00
Disclosure

SEC source: 0001907056-26-000028 · wk-form4_1790973122.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 234,527

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Read SEC document
September 22, 2026 Filed Sep 23, 2026 20:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 14,000 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000026 · wk-form4_1790194630.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,872

Underlying: Class A Common Stock · 14,000 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

F2 · derivative.exercise_date: This stock option award is fully vested.

Read SEC document
September 22, 2026 Filed Sep 23, 2026 20:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 29,277 $29.95 $876,846.15
Disclosure

SEC source: 0001907056-26-000026 · wk-form4_1790194630.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 236,527

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Read SEC document
September 22, 2026 Filed Sep 23, 2026 20:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 14,000 $5.01 $70,140.00
Disclosure

SEC source: 0001907056-26-000026 · wk-form4_1790194630.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 265,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Read SEC document
September 17, 2026 Filed Sep 18, 2026 20:17 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 12,313 $28.82 $354,860.66
Disclosure

SEC source: 0001907056-26-000024 · wk-form4_1789762639.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 251,804

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Read SEC document
August 19, 2026 Filed Aug 20, 2026 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 4,938 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000022 · wk-form4_1787257834.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,872

Underlying: Class A Common Stock · 4,938 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
August 19, 2026 Filed Aug 20, 2026 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 4,938 $29.99 $148,111.36
Disclosure

SEC source: 0001907056-26-000022 · wk-form4_1787257834.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 264,117

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 19, 2026 Filed Aug 20, 2026 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 4,938 $5.01 $24,739.38
Disclosure

SEC source: 0001907056-26-000022 · wk-form4_1787257834.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 269,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 9,388 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 10

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,810

Underlying: Class A Common Stock · 9,388 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F10 · derivative.exercise_date: This stock option award is fully vested.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,388 $27.89 $261,802.22
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 264,117

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.59 - $28.105. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 9,388 $5.01 $47,033.88
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,811 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 9

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 263,356

Underlying: Class A Common Stock · 18,811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F9 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

F9 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 11,482 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 8

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,825

Underlying: Class A Common Stock · 11,482 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F8 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.

F8 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 22,988 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 7

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,929

Underlying: Class A Common Stock · 22,988 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.

F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,335 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,669

Underlying: Class A Common Stock · 18,335 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 36,437 $28.15 $1,025,701.55
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 264,117

F4 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 71,616 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 300,554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
July 17, 2026 Filed Jul 20, 2026 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 7,163 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000020 · wk-form4_1784579422.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,198

Underlying: Class A Common Stock · 7,163 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
July 17, 2026 Filed Jul 20, 2026 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,163 $31.99 $229,168.01
Disclosure

SEC source: 0001907056-26-000020 · wk-form4_1784579422.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,321

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.93 - $32.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 17, 2026 Filed Jul 20, 2026 20:30 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 7,163 $5.01 $35,886.63
Disclosure

SEC source: 0001907056-26-000020 · wk-form4_1784579422.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 291,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
July 06, 2026 Filed Jul 7, 2026 20:20 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 7,163 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000018 · wk-form4_1783455644.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,361

Underlying: Class A Common Stock · 7,163 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
July 06, 2026 Filed Jul 7, 2026 20:20 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,163 $36.49 $261,351.37
Disclosure

SEC source: 0001907056-26-000018 · wk-form4_1783455644.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,321

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.35 - $36.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 06, 2026 Filed Jul 7, 2026 20:20 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 7,163 $5.01 $35,886.63
Disclosure

SEC source: 0001907056-26-000018 · wk-form4_1783455644.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 291,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
June 22, 2026 Filed Jun 23, 2026 22:39 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,376 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-26-000135 · wk-form4_1782254365.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,524

Underlying: Class A Common Stock · 6,376 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
June 22, 2026 Filed Jun 23, 2026 22:39 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 18,197 $34.03 $619,216.61
Disclosure

SEC source: 0001773751-26-000135 · wk-form4_1782254365.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,321

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.65 - $34.57. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 22, 2026 Filed Jun 23, 2026 22:39 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,376 $5.01 $31,943.76
Disclosure

SEC source: 0001773751-26-000135 · wk-form4_1782254365.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 302,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
June 18, 2026 Filed Aug 18, 2026 21:04 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 55,383 $35.09 $1,943,389.47
Disclosure

SEC source: 0001773751-26-000210 · wk-form4_1787087043.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 228,938

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.95 - $35.36. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 22:51 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,811 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 7

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,167

Underlying: Class A Common Stock · 18,811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F7 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

F7 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 22:51 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 11,483 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,307

Underlying: Class A Common Stock · 11,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 22:51 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 22,988 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,917

Underlying: Class A Common Stock · 22,988 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 22:51 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,334 $0.00 $0.00
Disclosure

SEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,004

Underlying: Class A Common Stock · 18,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 22:51 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 39,541 $30.17 $1,192,951.97
Disclosure

SEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,142

F3 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 22:51 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 71,616 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-26-000131 · wk-form4_1781736659.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F2 · balance_after: Includes 1,113 shares acquired on May 20, 2026, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.

Read SEC document
May 18, 2026 Filed May 19, 2026 23:39 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 7,950 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-26-000078 · wk-form4_1779233952.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,900

Underlying: Class A Common Stock · 7,950 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: The stock options are fully vested and exercisable.

Read SEC document
May 18, 2026 Filed May 19, 2026 23:39 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,950 $23.64 $187,915.74
Disclosure

SEC source: 0001773751-26-000078 · wk-form4_1779233952.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,954

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.55- $23.80. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 18, 2026 Filed May 19, 2026 23:39 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 7,950 $5.01 $39,829.50
Disclosure

SEC source: 0001773751-26-000078 · wk-form4_1779233952.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 270,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
April 20, 2026 Filed Apr 22, 2026 21:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 7,000 $0.00 Strike: $11.53 $0.00
Disclosure

SEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,996

Underlying: Class A Common Stock · 7,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F4 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Read SEC document
April 20, 2026 Filed Apr 22, 2026 21:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 5,553 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,850

Underlying: Class A Common Stock · 5,553 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: The stock options are fully vested and exercisable.

Read SEC document
April 20, 2026 Filed Apr 22, 2026 21:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 19,645 $29.96 $588,615.28
Disclosure

SEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,954

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 20, 2026 Filed Apr 22, 2026 21:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 7,000 $11.53 $80,710.00
Disclosure

SEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
April 20, 2026 Filed Apr 22, 2026 21:24 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 5,553 $5.01 $27,820.53
Disclosure

SEC source: 0001907056-26-000016 · wk-form4_1776893044.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 20:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,184 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,403

Underlying: Class A Common Stock · 6,184 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F4 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 20:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 18,005 $27.83 $501,158.37
Disclosure

SEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 270,046

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.70-$27.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 17, 2026 Filed Apr 20, 2026 20:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,184 $5.01 $30,981.84
Disclosure

SEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 288,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
April 16, 2026 Filed Apr 20, 2026 20:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 36,922 $25.90 $956,146.88
Disclosure

SEC source: 0001907056-26-000014 · wk-form4_1776717480.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,867

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.74-$26.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 06, 2026 Filed Apr 7, 2026 21:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 3,975 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001907056-26-000012 · wk-form4_1775596475.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,587

Underlying: Class A Common Stock · 3,975 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
April 06, 2026 Filed Apr 7, 2026 21:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,975 $19.98 $79,408.58
Disclosure

SEC source: 0001907056-26-000012 · wk-form4_1775596475.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 318,789

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95-$20.02). The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 06, 2026 Filed Apr 7, 2026 21:14 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 3,975 $5.01 $19,914.75
Disclosure

SEC source: 0001907056-26-000012 · wk-form4_1775596475.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 322,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 22:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 4,489 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-26-000051 · wk-form4_1774390195.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,562

Underlying: Class A Common Stock · 4,489 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
March 20, 2026 Filed Mar 24, 2026 22:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,217 $23.77 $219,066.89
Disclosure

SEC source: 0001773751-26-000051 · wk-form4_1774390195.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 318,789

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.73 - $23.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.